Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
#01 Back to the beginning: AIDS and the elusive vaccine
Two experimental vaccine approaches, using mRNA protein delivery and germline targeting, are in the early stages of development.
AVAC’s theme for HVAD 2021 is “HIV Vaccine Research: Building on Lessons from COVID.”
HTI vaccines could become the backbone of a combination approach for achieving a functional cure.
Young people account for 21% of new HIV diagnoses annually. Our April/May issue looks at ways to raise HIV awareness among youth.
I just attended my first CROI (Conference on Retroviruses and Opportunistic Infections). It was also my first virtual conference...
Abbott researchers found a high proportion of elite HIV controllers in the Democratic Republic of Congo, which could lead to cure insights.
COVID-19, HIV vaccines, cure news and long-acting injectables stood out among the top HIV treatment stories of the year.
A survey of 6,500 HIV vaccine trial participants found that the good feeling involved with being altruistic was a major benefit.
Social media posts that make misleading comparisons undermine the science behind the COVID-19 vaccine.
New mRNA vaccine approach protects monkeys from HIV-like virus.
Researchers believe that in addition to producing antibodies against the virus, vaccines must also give rise to a cellular immune response.
The NIH-funded network has launched its first clinical trial in response to the new pandemic.
Large trial of HIV vaccine finds it does not prevent HIV
Monday, May 18 is HIV Vaccine Advocacy Day. Support science. Not sound bites.
The new coronavirus crisis has upended the clinical trials process around the world.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.